Display of Native SARS-CoV-2 Spike on Mammalian Cells to Measure Antibody Affinity and ADCC
The COVID-19 pandemic led to the rapid development of antibody-based therapeutics and vaccines targeting the SARS-CoV-2 spike protein. Several antibodies have been instrumental in protecting vulnerable populations, but their utility was limited by the emergence of spike variants with diminished susc...
Saved in:
| Main Authors: | Rebecca Wilen, Annalee Nguyen, Ahlam Qerqez, Jennifer Maynard |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bio-protocol LLC
2024-11-01
|
| Series: | Bio-Protocol |
| Online Access: | https://bio-protocol.org/en/bpdetail?id=5119&type=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS‐CoV‐2 spike protein
by: Lydia Horndler, et al.
Published: (2021-02-01) -
SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01) -
A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies
by: Christophe Lallemand, et al.
Published: (2017-01-01) -
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins.
by: Carina Conceicao, et al.
Published: (2020-12-01) -
ADCC: the rock band led by therapeutic antibodies, tumor and immune cells
by: Roos Vincken, et al.
Published: (2025-04-01)